Clinical Trials
5 trialsNCT03520660 2026-06-03
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT07557914 2026-06-03
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
First Hospital of China Medical University
Phase 2 Not yet recruiting
NCT00469339 2026-05-22
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
Completed
NCT03937453 2026-04-13
PANDOME
Nuvance Health
Recruiting
NCT06803771 2026-03-23
SAFE-D
University Hospital Southampton NHS Foundation Trust
Phase NA Recruiting